WallStreetZenWallStreetZen

NYSE: ADCT
Adc Therapeutics Sa Stock Ownership - Who owns Adc Therapeutics Sa?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Adc Therapeutics Sa insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Redmile Group LLC10% Owner2026-04-022,529,491$3.28
$8.29MSell
Redmile Group LLC10% Owner2026-04-022,634,506$3.28
$8.64MSell
Redmile Group LLC10% Owner2026-04-01162,517$3.80
$617.40kSell
Redmile Group LLC10% Owner2026-04-01169,265$3.80
$643.04kSell
Redmile Group LLC10% Owner2026-03-31188,407$3.75
$706.90kSell
Redmile Group LLC10% Owner2026-03-31196,229$3.75
$736.25kSell
Lisa Michelle KalleboChief Accounting Officer2026-02-135,433$3.99
$21.68kSell
Ameet MallikChief Executive Officer2026-02-13900,000$3.99
$3.59MBuy
Ameet MallikChief Executive Officer2026-02-13103,231$3.99
$411.89kSell
Mohamed ZakiChief Medical Officer2026-02-1324,603$3.99
$98.17kSell

1 of 3

ADCT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ADCT insiders and whales buy or sell their stock.

ADCT Shareholders

What type of owners hold Adc Therapeutics Sa stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Redmile Group LLC30.35%38,598,759$122.36MInsider
Redmile Group LLC12.16%15,470,502$49.04MInstitution
Tcg Crossover Management LLC8.96%11,390,175$36.11MInstitution
Hans Peter Wild7.70%9,788,944$31.03MInsider
Prosight Management LP6.53%8,300,000$26.31MInstitution
Blackrock Inc4.91%6,250,747$19.81MInstitution
Eventide Asset Management LLC4.48%5,701,655$18.07MInstitution
Nantahala Capital Management LLC4.40%5,597,433$17.74MInstitution
Morgan Stanley3.00%3,812,582$12.09MInstitution
Point72 Asset Management LP2.66%3,382,129$10.72MInstitution

1 of 3

ADCT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADCT60.69%39.31%Net SellingNet Selling
ENTA65.29%34.71%Net Selling
SGMT21.82%35.89%Net Selling
FULC71.28%28.72%Net Selling
REPL65.66%34.34%Net SellingNet Selling
View Top Biotech Stocks

Adc Therapeutics Sa Stock Ownership FAQ

Who owns Adc Therapeutics Sa?

Adc Therapeutics Sa (NYSE: ADCT) is owned by 65.66% institutional shareholders, 42.53% Adc Therapeutics Sa insiders, and 0.00% retail investors. Redmile Group LLC is the largest individual Adc Therapeutics Sa shareholder, owning 38.60M shares representing 30.35% of the company. Redmile Group LLC's Adc Therapeutics Sa shares are currently valued at $121.20M.

If you're new to stock investing, here's how to buy Adc Therapeutics Sa stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.